PRRT2 and cancer: Treatment of head and neck squamous carcinoma cells (HNSCC) with N-(4-hydroxyphenyl)retinamide (4HPR), a synthetic retinoid effective in cancer chemoprevention and therapy was shown to increase mitochondrial ROS generation, which in turns activates PKC and MAPK kinases (MKK4,MKK3/6).